Personalized treatment using predictive biomarkers in solid organ malignancies: A review
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Predictive biomarkers are crucial for personalized cancer treatment, improving diagnosis, treatment selection, and monitoring for solid organ malignancies. Their application guides effective management and enhances patient outcomes in various cancers.
Area Of Science
- Oncology
- Biomarker Research
- Personalized Medicine
Background
- Biomarkers are increasingly vital in diagnosing and predicting outcomes for solid organ cancers.
- Predictive biomarkers guide personalized treatment strategies, impacting cancer management from initiation to long-term adjustment.
Purpose Of The Study
- To review the application of predictive biomarkers in treating solid organ malignancies.
- To analyze the goals, types, and clinical efficacy of personalized cancer treatment using predictive biomarkers.
Main Methods
- Literature review focusing on predictive biomarkers in solid organ cancers.
- Analysis of biomarker-guided treatment strategies for common and high-mortality cancers.
- Evaluation of the relative efficacies of predictive biomarkers in clinical settings.
Main Results
- Predictive biomarkers significantly influence diagnosis, treatment initiation, and monitoring of treatment efficacy and side effects.
- Personalized treatment approaches utilizing predictive biomarkers are effective across diverse solid organ malignancies.
- The review covers colorectal, breast, lung, prostate, pancreatic, liver, kidney, and central nervous system cancers.
Conclusions
- Predictive biomarkers are essential for advancing personalized oncology and optimizing solid organ malignancy treatment.
- The integration of predictive biomarkers enhances treatment efficacy and patient management in clinical practice.
- Further research into biomarker-driven therapies promises improved outcomes for various cancer types.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...